Maria do Carmo Costa

4.2k total citations
37 papers, 1.3k citations indexed

About

Maria do Carmo Costa is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Neurology. According to data from OpenAlex, Maria do Carmo Costa has authored 37 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Cellular and Molecular Neuroscience, 32 papers in Molecular Biology and 9 papers in Neurology. Recurrent topics in Maria do Carmo Costa's work include Genetic Neurodegenerative Diseases (33 papers), Mitochondrial Function and Pathology (26 papers) and Ubiquitin and proteasome pathways (6 papers). Maria do Carmo Costa is often cited by papers focused on Genetic Neurodegenerative Diseases (33 papers), Mitochondrial Function and Pathology (26 papers) and Ubiquitin and proteasome pathways (6 papers). Maria do Carmo Costa collaborates with scholars based in United States, Portugal and Canada. Maria do Carmo Costa's co-authors include Henry L. Paulson, Patrı́cia Maciel, Vikram G. Shakkottai, Heike Wulff, Ananthakrishnan Sankaranarayanan, James Dell’Orco, Jorge Sequeiros, Svetlana Fischer, Beverly L. Davidson and Edgardo Rodríguez-Lebrón and has published in prestigious journals such as Journal of Neuroscience, PLoS ONE and Journal of Molecular Biology.

In The Last Decade

Maria do Carmo Costa

37 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Maria do Carmo Costa United States 22 1.1k 988 298 89 82 37 1.3k
Warunee Dansithong United States 19 1.0k 1.0× 732 0.7× 218 0.7× 50 0.6× 82 1.0× 35 1.2k
Jeannette Hübener‐Schmid Germany 15 557 0.5× 598 0.6× 251 0.8× 60 0.7× 51 0.6× 30 813
Sharan Paul United States 19 1.0k 0.9× 688 0.7× 220 0.7× 41 0.5× 81 1.0× 37 1.2k
Refugio A. Martinez United States 13 707 0.7× 441 0.4× 145 0.5× 95 1.1× 73 0.9× 18 930
Astrid Lunkes Germany 12 1.4k 1.4× 1.5k 1.5× 648 2.2× 33 0.4× 99 1.2× 18 1.8k
Alice B. Schindler United States 15 607 0.6× 396 0.4× 202 0.7× 60 0.7× 104 1.3× 37 1.0k
Madoka Iida Japan 16 446 0.4× 354 0.4× 237 0.8× 69 0.8× 43 0.5× 41 847
Marija Cvetanović United States 20 653 0.6× 495 0.5× 153 0.5× 56 0.6× 77 0.9× 39 1.1k
Joline Dalton United States 10 898 0.9× 817 0.8× 290 1.0× 11 0.1× 98 1.2× 18 1.1k
Ting Zhao China 14 681 0.6× 309 0.3× 125 0.4× 54 0.6× 103 1.3× 26 922

Countries citing papers authored by Maria do Carmo Costa

Since Specialization
Citations

This map shows the geographic impact of Maria do Carmo Costa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maria do Carmo Costa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maria do Carmo Costa more than expected).

Fields of papers citing papers by Maria do Carmo Costa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maria do Carmo Costa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maria do Carmo Costa. The network helps show where Maria do Carmo Costa may publish in the future.

Co-authorship network of co-authors of Maria do Carmo Costa

This figure shows the co-authorship network connecting the top 25 collaborators of Maria do Carmo Costa. A scholar is included among the top collaborators of Maria do Carmo Costa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maria do Carmo Costa. Maria do Carmo Costa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Raposo, Mafalda, João Vasconcelos, Teresa Kay, et al.. (2025). Blood DDIT4 and TRIM13 Transcript Levels Mark the Early Stages of Machado–Joseph Disease. Annals of Neurology. 98(1). 107–119. 1 indexed citations
2.
Mengel, David, et al.. (2023). Blood levels of neurofilament light are associated with disease progression in a mouse model of spinocerebellar ataxia type 3. Disease Models & Mechanisms. 16(9). 3 indexed citations
3.
Raposo, Mafalda, Matthew W. Perkins, João Vasconcelos, et al.. (2023). Tissue-Specific Vulnerability to Apoptosis in Machado-Joseph Disease. Cells. 12(10). 1404–1404. 6 indexed citations
4.
Casaroli‐Marano, Ricardo P., Marc Figueras‐Roca, Bernardo Sánchez‐Dalmau, et al.. (2022). Altered retinal structure and function in Spinocerebellar ataxia type 3. Neurobiology of Disease. 170. 105774–105774. 4 indexed citations
5.
Abril, Josep F., Sokol V. Todi, Naheed W. Khan, et al.. (2020). The Deubiquitinating Enzyme Ataxin-3 Regulates Ciliogenesis and Phagocytosis in the Retina. Cell Reports. 33(6). 108360–108360. 21 indexed citations
6.
Raposo, Mafalda, et al.. (2019). Selection of Reference Genes for Normalization of Gene Expression Data in Blood of Machado-Joseph Disease/Spinocerebellar Ataxia Type 3 (MJD/SCA3) Subjects. Journal of Molecular Neuroscience. 69(3). 450–455. 3 indexed citations
7.
Todi, Sokol V., et al.. (2019). Druggable genome screen identifies new regulators of the abundance and toxicity of ATXN3, the Spinocerebellar Ataxia type 3 disease protein. Neurobiology of Disease. 137. 104697–104697. 15 indexed citations
8.
Duarte‐Silva, Sara, et al.. (2018). Citalopram Reduces Aggregation of ATXN3 in a YAC Transgenic Mouse Model of Machado-Joseph Disease. Molecular Neurobiology. 56(5). 3690–3701. 17 indexed citations
9.
Rodríguez-Lebrón, Edgardo, Maria do Carmo Costa, Svetlana Fischer, et al.. (2013). Silencing Mutant ATXN3 Expression Resolves Molecular Phenotypes in SCA3 Transgenic Mice. Molecular Therapy. 21(10). 1909–1918. 87 indexed citations
10.
Costa, Maria do Carmo, Svetlana Fischer, Michelle Ouyang, et al.. (2013). Toward RNAi Therapy for the Polyglutamine Disease Machado–Joseph Disease. Molecular Therapy. 21(10). 1898–1908. 84 indexed citations
11.
Shakkottai, Vikram G., Maria do Carmo Costa, James Dell’Orco, et al.. (2011). Early Changes in Cerebellar Physiology Accompany Motor Dysfunction in the Polyglutamine Disease Spinocerebellar Ataxia Type 3. Journal of Neuroscience. 31(36). 13002–13014. 162 indexed citations
12.
Costa, Maria do Carmo & Henry L. Paulson. (2011). Toward understanding Machado–Joseph disease. Progress in Neurobiology. 97(2). 239–257. 202 indexed citations
13.
Rodrigues, Ana João, Maria do Carmo Costa, Teresa Luísa Silva, et al.. (2010). Absence of ataxin-3 leads to cytoskeletal disorganization and increased cell death. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1803(10). 1154–1163. 39 indexed citations
14.
Costa, Maria do Carmo, Fernanda Bajanca, Ana João Rodrigues, et al.. (2010). Ataxin-3 Plays a Role in Mouse Myogenic Differentiation through Regulation of Integrin Subunit Levels. PLoS ONE. 5(7). e11728–e11728. 24 indexed citations
15.
Silva‐Fernandes, Anabela, Maria do Carmo Costa, Sara Duarte‐Silva, et al.. (2010). Motor uncoordination and neuropathology in a transgenic mouse model of Machado–Joseph disease lacking intranuclear inclusions and ataxin-3 cleavage products. Neurobiology of Disease. 40(1). 163–176. 53 indexed citations
16.
Costa, Maria do Carmo, Andreia Teixeira‐Castro, Marco Constante, et al.. (2006). Exclusion of mutations in the PRNP, JPH3, TBP, ATN1, CREBBP, POU3F2 and FTL genes as a cause of disease in Portuguese patients with a Huntington-like phenotype. Journal of Human Genetics. 51(8). 645–651. 23 indexed citations
17.
Costa, Maria do Carmo, Cristina Costa, Ana Paula Silva, et al.. (2005). Nonsense mutation in TITF1 in a Portuguese family with benign hereditary chorea. Neurogenetics. 6(4). 209–215. 34 indexed citations
18.
Gales, Luı́s, Luísa Cortes, Carla Almeida, et al.. (2005). Towards a Structural Understanding of the Fibrillization Pathway in Machado-Joseph's Disease: Trapping Early Oligomers of Non-expanded Ataxin-3. Journal of Molecular Biology. 353(3). 642–654. 60 indexed citations
19.
Costa, Maria do Carmo, et al.. (2004). Genomic structure, promoter activity, and developmental expression of the mouse homologue of the Machado–Joseph disease (MJD) gene☆. Genomics. 84(2). 361–373. 23 indexed citations
20.
Costa, Maria do Carmo, Jorge Sequeiros, & Patrı́cia Maciel. (2002). Identification of three novel polymorphisms in the MJD1 gene and study of their frequency in the Portuguese population. Journal of Human Genetics. 47(4). 205–207. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Warunee Dansithong Breakdown of academic impact, for papers by Jeannette Hübener‐Schmid Breakdown of academic impact, for papers by Sharan Paul Breakdown of academic impact, for papers by Refugio A. Martinez Breakdown of academic impact, for papers by Astrid Lunkes Breakdown of academic impact, for papers by Alice B. Schindler Breakdown of academic impact, for papers by Madoka Iida Breakdown of academic impact, for papers by Marija Cvetanović Breakdown of academic impact, for papers by Joline Dalton Breakdown of academic impact, for papers by Ting Zhao
Rankless by CCL
2026